Second Line Capital »

Ocular Therapeutix shares owned by Second Line Capital

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Second Line Capital from 13F filings

Historical chart of Second Line Capital investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Second Line Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Second Line Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3M 263k 8.70
2024-06-30 $1.8M 263k 6.84

More positions owned by Second Line Capital

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Etf Ser Solutions Aptus Drawdown (ADME)
Etf Ser Solutions Aptus Enhanced (JUCY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Etf Ser Solutions Aptus Large Cap (DUBS)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
Apple (AAPL)

View all positions for Second Line Capital

Top funds holding Ocular Therapeutix

Summer Road
VR Adviser
Deep Track Capital
BlackRock
BlackRock
Vanguard Group
TCG Crossover Management
Logos Global Management
Opaleye Management
Citadel Advisors
State Street Corporation
Perceptive Advisors
Geode Capital Management
Assenagon Asset Management
Deltec Asset Management

View all funds holding Ocular Therapeutix